Answers are grounded in this paper and cite their sources.
Randomized double-blind placebo-controlled trial finds corticosteroid nasal irrigations superior to sprays in postsurgical chronic rhinosinusitis, highlighting improved drug delivery.
In the setting of diffuse or patchy CRS disease, the use of corticosteroid delivered by nasal irrigation is superior to simple nasal spray in postsurgical patients.
No takes yet. Share an insight, caveat, or question.
Harvey et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: